Regenerative ophthalmology is focused on restoring, repairing, or replacing damaged ocular tissues, neural pathways, and visual function through biological and regenerative strategies. Unlike conventional approaches that primarily aim to manage disease progression or alleviate symptoms, regenerative ophthalmology seeks to restore vision by addressing the underlying cellular and molecular mechanisms of tissue damage and dysfunction.
At the Shiley Eye Institute, regenerative approaches are being investigated to develop novel therapies for vision loss and blinding eye diseases. The newly established Viterbi Family Vision Research Center provides an interdisciplinary environment designed to facilitate collaborative, translational research in areas including gene-based therapies, stem cell biology, cellular engineering, and other regenerative technologies. The Gleiberman Center for Glaucoma Research is focused on reversing glaucoma blindness. These efforts are directed toward advancing therapeutic strategies capable of restoring visual function in patients with currently irreversible conditions, including glaucoma and retinal degenerative diseases.
